The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Global trends in molecular epidemiology of HIV-1 during 2000–2007
Open accessAbstract
OBJECTIVE: To estimate the global and regional distribution of HIV-1 subtypes and recombinants between 2000 and 2007. DESIGN: Country-specific HIV-1 molecular epidemiology data were combined with estimates of the number of HIV-infected people in each country. METHODS: Cross-sectional HIV-1 subtyping data were collected from 65 913 samples in 109 countries between 2000 and 2007. The distribution of HIV-1 subtypes in individual countries was weighted according to the number of HIV-infected people in each country to generate estimates of regional and global HIV-1 subtype distribution for the periods 2000-2003 and 2004-2007. RESULTS: Analysis of the global distribution of HIV-1 subtypes and recombinants in the two periods indicated a broadly stable distribution of HIV-1 subtypes worldwide with a notable increase in the proportion of circulating recombinant forms (CRFs), a decrease in unique recombinant forms (URFs) and an overall increase in recombinants. In 2004-2007, subtype C accounted for nearly half (48%) of all global infections, followed by subtypes A (12%) and B (11%), CRF02_AG (8%), CRF01_AE (5%), subtype G (5%) and D (2%). Subtypes F, H, J and K together cause fewer than 1% of infections worldwide. Other CRFs and URFs are each responsible for 4% of global infections, bringing the combined total of worldwide CRFs to 16% and all recombinants (CRFs along with URFs) to 20%. CONCLUSION: The global and regional distributions of individual subtypes and recombinants are broadly stable, although CRFs may play an increasing role in the HIV pandemic. The global diversity of HIV-1 poses a formidable challenge to HIV vaccine development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908492 · Cited by 3,034
Antibody neutralization and escape by HIV-1
Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature · doi:10.1038/nature01470 · Cited by 2,421
Buchbinder, S. P., Mehrotra, D. V., Duerr, A., Fitzgerald, D. W., Mogg, R., Li, D., Gilbert, P. B., Lama, J. R., Marmor, M., del Rio, C., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61591-3 · Cited by 1,713
Robertson, D. L., Anderson, J. P., Bradac, J. A., Carr, J. K., Foley, B., Funkhouser, R. K., Gao, F., Hahn, B. H., Kalish, M. L., Kuiken, C., et al. (2000) · Science · doi:10.1126/science.288.5463.55d · Cited by 964
Self-citationChimpanzee Reservoirs of Pandemic and Nonpandemic HIV-1
Keele, B. F., Van Heuverswyn, F., Li, Y., Bailes, E., Takehisa, J., Santiago, M. L., Bibollet-Ruche, F., Chen, Y., Wain, L. V., Liegeois, F., et al. (2006) · Science · doi:10.1126/science.1126531 · Cited by 957
Pitisuttithum, P., Gilbert, P., Gurwith, M., Heyward, W., Martin, M., van Griensven, F., Hu, D., Tappero, J. W., Choopanya, K., & Bangkok Vaccine Evaluation Group (2006) · The Journal of Infectious Diseases · doi:10.1086/508748 · Cited by 847
Diversity Considerations in HIV-1 Vaccine Selection
Gaschen, B., Taylor, J., Yusim, K., Foley, B., Gao, F., Lang, D., Novitsky, V., Haynes, B., Hahn, B. H., Bhattacharya, T., et al. (2002) · Science · doi:10.1126/science.1070441 · Cited by 811
Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960
Worobey, M., Gemmel, M., Teuwen, D. E., Haselkorn, T., Kunstman, K., Bunce, M., Muyembe, J.-J., Kabongo, J.-M. M., Kalengayi, R. M., Van Marck, E., et al. (2008) · Nature · doi:10.1038/nature07390 · Cited by 650
Goonetilleke, N., Liu, M. K. P., Salazar-Gonzalez, J. F., Ferrari, G., Giorgi, E., Ganusov, V. V., Keele, B. F., Learn, G. H., Turnbull, E. L., Salazar, M. G., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090365 · Cited by 641
Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004
Hemelaar, J., Gouws, E., Ghys, P. D., & Osmanov, S. (2006) · AIDS · doi:10.1097/01.aids.0000247564.73009.bc · Cited by 629
Self-citationA new human immunodeficiency virus derived from gorillas
Plantier, J.-C., Leoz, M., Dickerson, J. E., De Oliveira, F., Cordonnier, F., Lemée, V., Damond, F., Robertson, D. L., & Simon, F. (2009) · Nature Medicine · doi:10.1038/nm.2016 · Cited by 595
Evolutionary and immunological implications of contemporary HIV-1 variation
Korber, B., Gaschen, B., Yusim, K., Thakallapally, R., Kesmir, C., & Detours, V. (2001) · British Medical Bulletin · doi:10.1093/bmb/58.1.19 · Cited by 540
Challenges in the development of an HIV-1 vaccine
Barouch, D. H. (2008) · Nature · doi:10.1038/nature07352 · Cited by 380
Kiwanuka, N., Laeyendecker, O., Robb, M., Kigozi, G., Arroyo, M., McCutchan, F., Eller, L. A., Eller, M., Makumbi, F., Birx, D., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/527416 · Cited by 264
Vasan, A., Renjifo, B., Hertzmark, E., Chaplin, B., Msamanga, G., Essex, M., Fawzi, W., & Hunter, D. (2006) · Clinical Infectious Diseases · doi:10.1086/499952 · Cited by 201
Is HIV-1 evolving to a less virulent form in humans?
Ariën, K. K., Vanham, G., & Arts, E. J. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1594 · Cited by 189
T Cell Cross-Reactivity and Conformational Changes during TCR Engagement
Lee, J. K., Stewart-Jones, G., Dong, T., Harlos, K., Di Gleria, K., Dorrell, L., Douek, D. C., van der Merwe, P. A., Jones, E. Y., & McMichael, A. J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041251 · Cited by 161
Spatial phylodynamics of HIV-1 epidemic emergence in east Africa
Gray, R. R., Tatem, A. J., Lamers, S. L., Hou, W., Laeyendecker, O. B., Serwadda, D., Sewankambo, N. K., Gray, R. H., Wawer, M. J., Quinn, T. C., et al. (2009) · AIDS · doi:10.1097/qad.0b013e32832faf61 · Cited by 104
Kiwanuka, N., Laeyendecker, O. B., Quinn, T. C., Wawer, M. J., Shepherd, J., Robb, M., Kigozi, G., Kagaayi, J., Serwadda, D., Makumbi, F., et al. (2009) · AIDS · doi:10.1097/qad.0b013e328330cc08 · Cited by 100
HIV vaccines: mosaic approach to virus diversity
Corey, L., & McElrath, M. J. (2010) · Nature Medicine · doi:10.1038/nm0310-268 · Cited by 34
Cited by
HIV infection: epidemiology, pathogenesis, treatment, and prevention
Maartens, G., Celum, C., & Lewin, S. R. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60164-1 · Cited by 830
The early spread and epidemic ignition of HIV-1 in human populations
Faria, N. R., Rambaut, A., Suchard, M. A., Baele, G., Bedford, T., Ward, M. J., Tatem, A. J., Sousa, J. D., Arinaminpathy, N., Pépin, J., et al. (2014) · Science · doi:10.1126/science.1256739 · Cited by 736
Improving Bayesian Population Dynamics Inference: A Coalescent-Based Model for Multiple Loci
Gill, M. S., Lemey, P., Faria, N. R., Rambaut, A., Shapiro, B., & Suchard, M. A. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mss265 · Cited by 553
Recombination in viruses: Mechanisms, methods of study, and evolutionary consequences
Pérez-Losada, M., Arenas, M., Galán, J. C., Palero, F., & González-Candelas, F. (2015) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2014.12.022 · Cited by 450
The origin and diversity of the HIV-1 pandemic
Hemelaar, J. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.12.001 · Cited by 427
Self-citation
Metadata
- Authors
- Hemelaar, J., Gouws, E., Ghys, P. D., & Osmanov, S.
- Venue
- AIDS
- Published
- 2011-03-13
- Volume
- 25
- Issue
- 5
- Pages
- 679-689
- ISSN
- 0269-9370 (ISSN-L)
- OpenAlex
- W2089135598
- Cited by
- 692
- References
- 20
- FWCI
- 61.47
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.